Background Hepatocyte nuclear factor-1α gene (HNF1A) single nucleotide polymorphisms
have focused on in the present study is chromosome 12q, especially hepatocyte nuclear factor-1a gene (HNF1A), because this chromosomal arm is associated with CAD. 7, 8 CAD may share some common risk factors with IS, such as hypertension, dyslipidemia and genetic variants. 6 However, it is unknown whether the single nucleotide polymorphisms (SNPs) associated with the risk of CAD are also associated with the risk of IS.
The HNF1A (also known as TCF1) product, HNF-1a, is a transcriptional activator of several hepatic genes. This gene is expressed in the pancreas, liver, intestine and kidneys. 9 HNF-1a binds to genes whose products are involved in hepatic biochemistry, including carbohydrate synthesis and storage, lipid metabolism, detoxification, and synthesis of serum proteins. 10 Mutations in the HNF1A cause maturity onset diabetes of the young [10] [11] [12] and affect plasma concentrations of C-reactive protein. 13 In addition, the SNPs in the HNF1A
have been associated with levels of low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC) 14, 15 and triglyceride (TG), 16 as well as high plasma concentrations of high-density lipoprotein cholesterol (HDL-C) and apolipoprotein (Apo) A1. 17, 18 However, it is not known whether the variants in the HNF1A are also associated with the risk of dyslipidemia, CAD and IS in the Chinese populations.
According to previous genome-wide association studies (GWAS), some loci in the HNF1A have pleiotropic effects on several metabolic traits. Therefore, in the present study, we assessed the association of the HNF1A rs1169288, rs2259820, rs2464196, rs2650000 SNPs and serum lipid levels and the risk of CAD and IS.
| MATERIALS AND METHODS

| Study subjects
A total of 562 patients with CAD and 521 patients with IS were recruited from hospitalized patients in the First Affiliated Hospital, Guangxi Medical University. All of the enrolled CAD patients were evaluated by coronary angiography because of suspected CAD or unrelated conditions requiring angiographic evaluation; the coronary angiograms were analyzed by two experienced interventional cardiologists. CAD was defined as significant coronary stenosis (≥ 50%) in at least one of the three main coronary arteries or their major branches (branch diameter ≥ 2 mm). Subjects with congenital heart disease and type I diabetes mellitus were excluded. All of the enrolled IS patients received a strict neurological examination and brain magnetic resonance imaging. The diagnosis of IS was made according to the International Classification of Diseases (9th Revision). Patients with a transient ischemic attack, embolic brain infarction, stroke caused by inflammatory disease, cardio-embolic stroke, autoimmune disease or serious chronic diseases were excluded from the study. Subjects with a past history of CAD were also excluded from the study. 19 A total of 594 healthy controls matched by age, sex and geographical area were also included. The controls were judged to be free of CAD and IS by questionnaires, medical history and clinical examination.
All individuals enrolled were from the Han population in Guangxi, China. A standard questionnaire was used to ascertain general information and medical history from all participants. The study protocol was approved by the Ethics Committee of the First Affiliated Hospital, Guangxi Medical University. Informed consent was obtained from all subjects after they had received a full explanation of the study.
| SNP selection
We selected four SNPs in the HNF1A on the basis of: (1) 
| Biochemical analysis
All of the biochemical assays and genotyping in CAD and IS patients were performed after hospitalization, and all of the venous blood samples were obtained from the patients and controls after at least 12 h of fasting. The levels of TC, TG, HDL-C and LDL-C in the samples were determined by enzymatic methods with commercially available kits.
Serum apolipoprotein A1 (ApoA1) and apolipoprotein B (ApoB) levels were detected by an immunoturbidimetric immunoassay using a commercial kit (RANDOX Laboratories Ltd, Crumlin, UK). 20 The normal values of serum TC, TG, HDL-C and LDL-C; ApoA1 and ApoB; and the ApoA1/ApoB ratio at our Clinical Science Experiment Center were The association between genotypes and serum lipid parameters was tested by analysis of covariance. Any variants associated with the serum lipid parameter at p < 0.013 (corresponding to p < 0.05 after adjusting for four independent tests by Bonferroni correction) were considered statistically significant. Unconditional logistic regression was used to assess the correlation between the risk of CAD or IS and genotypes. Sex, age, body mass index (BMI), blood pressure, alcohol consumption and cigarette smoking were adjusted for the statistical analysis. p < 0.05 (two-tailed) was considered to be statistically significant.
The interlocus interaction was analyzed by the generalized multifactor dimensionality reduction (GMDR) method, using GMDR soft- 3 | RESULTS Table 1 compares the general characteristics and serum lipid levels between the healthy controls and CAD or IS patients. Mean age, sex distribution, serum LDL-C and ApoB levels were not different between controls and CAD or IS patients (p > 0.05 for all). CAD patients had higher BMI, pulse pressure and serum TG levels, but lower diastolic blood pressure, serum TC, HDL-C, ApoA1 levels and ApoA1/ApoB ratio. The IS patients had higher BMI, systolic blood pressure, pulse pressure and serum TG levels, as well as lower serum TC, HDL-C, ApoA1 levels and ApoA1/ApoB ratio. SNPs were no different between controls and CAD or IS patients (p > 0.05 for all). Significant linkage disequilibrium (LD) was noted among the rs1169288, rs2259820, rs2464196 and rs2650000 SNPs (r 2 > 0.5, D′ > 0.8).
| Characteristics of the subjects
| Genotype and allele frequencies
| Genotypes and serum lipid levels
As shown in Table 3 , after Bonferroni correction of p-values, the minor C allele of rs1169288 was associated with high TG concentrations in controls (p < 0.01); the minor T allele of rs2259820 and the minor of A allele of rs2464196 were associated with high ApoA1 concentrations in CAD patients (p < 0.01), respectively. We found that four SNPs were not associated with lipoprotein or lipid-related traits in IS patients (p > 0.05), respectively.
3.4 | HNF1A SNPs and the risk of CAD and IS Table 4 shows the association of the HNF1A SNPs and the risk of CAD and IS. SNPs of rs2259820 and rs2464196 were significantly associ- 
| Haplotypes and the risk of CAD and IS
As shown in Table 5 , the haplotype of A-C-G-C (in the order of the rs1169288, rs2259820, rs2464196 and rs2650000 SNPs) was the commonest haplotype and represented approximately 50% of the sample. The haplotype of A-C-G-A, carrying rs2259820C and rs2464196G alleles, was associated with an increased risk of CAD (OR =1.95, 95% CI -1.13-3.37, p = 0.015).
3.6 | Gene-gene interactions for CAD and IS Table 6 shows the impacts of the HNF1A SNPs for CAD and IS. The one-and three-locus models showed a significant association with the risk of CAD (p < 0.05-0.02). The three-locus model was chosen as the best because it had the highest level of testing accuracy (53% for CAD) and good cross-validation consistency (10/10). However, we did not find any impact of the HNF1A SNPs on IS.
| Interactions of the haplotypes and environment factors on the risk of CAD
Interactions of one haplotype and smoking on the risk of CAD were noted in the present study. Compared to the A-C-G-C haplotype in nonsmokers, the haplotype of A-C-G-A (OR =0.51, 95% CI = 0.26-0.98) in nonsmokers was associated with a decreased risk for CAD.
| Interactions of the haplotypes and environment factors on the risk of IS
The interactions of several haplotypes and alcohol consumption, as well as sex, on the risk of IS were also noted in the present study. The values of TG are presented as the median (interquartile range) and the difference among the genotypes was determined by the Kruskal-Wallis test. p < 0.013 (corresponding to p < 0.05 after adjusting for four independent tests by the Bonferroni correction) was considered statistically significant. In the present study, we observed that the HNF1A rs2259820 and rs2464196 SNPs were related to ApoA1 concentrations in CAD patients. The HNF1A rs2259820T and rs2464196A allele carriers in CAD patients had higher ApoA1 concentrations than the rs2259820T and rs2464196A allele noncarriers. A previous study reported that one HNF1A mutation (G319S) was associated with ApoA1 concentration in Canadian Oji-Cree and suggested that the relationship was mediated through differences in plasma insulin concentration. 17 Another direct mechanism could explain this association.
HNF-1 strongly downregulated transcription driven by its own promoter in HepG2 cells and repressed the activity of HNF-4 (hepatocyte nuclear factor 4), which is a major positive regulator of a different set of liver genes, including ApoA1 and ApoCIII. 21 Interestingly, no association of the HNF1A SNPs and serum TC, LDL-C and HDL-C levels was found in our study populations, although previous studies had speculated there might be one. We conjecture that these features may have more important determinants rather than the HNF1A SNPs in Chinese people. It may be the expression of other gene products or the environmental factors that are involved in lipid metabolism.
We also found that the minor rs1169288C allele was associated with high TG concentrations in the controls. In a previous study, Chiu et al. 22 showed that the HNF1A rs1169288 (I27L) was associated with insulin resistance. Subjects with the LL genotype had higher insulin resistance than those with IL and II genotypes. 22 Furthermore, some studies found that insulin resistance could inhibit ApoA5 mRNA expression in HepG2 cells of humans and rodents. 23, 24 ApoA5 was an important determinant of plasma TG levels. Knockout mice without the ApoA5 gene led to increased plasma TG, whereas its overexpression resulted in a reduction of TG. 25, 26 By contrast, one cross-sectional study with a sample of Brazilian diabetic individuals demonstrated that the presence of the I27L variant can show a 'protective effect' with respect to the risk of hypertriglyceridemia. 16 Thus, differences in genetic traits among studied populations or statistical methodology are a possible explanation for the association of the variants in the HNF1A and serum lipid levels. We could not exclude the possibility that the HNF1A was in LD with a functional variant of another gene on chromosome 12 that had been found in association with TG in GWAS.
Some studies found that genetic loci associated with LDL-C, TC, HDL-C and ApoA1 were also associated with the risk of CAD. [27] [28] [29] In addition, clinical studies showed that ApoB100/ApoA1 significantly increased the risk of CAD. 30 A low level of ApoA1 could increase the risk of death in patients with CAD 31 and be an independent risk factor for CAD patients. 32 Erdmann et al. 7 found a possible association of CAD risk and rs2259816 SNP in a German population. The HNF1A rs1169288 and rs2464196 SNPs were also associated with an increased risk of CAD in the general population of younger and older European-American adults. 8 Our findings show for the first time that two SNPs at the HNF1A locus (rs2259820T and rs2464196A alleles) associated with higher serum ApoA1 levels consistently decreased the risk of CAD in Chinese people. In addition, we noted that the haplotype of A-C-G-A, carrying rs2259820C and rs2464196G alleles, was associated with an increased risk of CAD. This might be associated with decreased C-reactive protein level, an inflammatory biomarker that predicts future cardiovascular events. [33] [34] [35] [36] An interlocus interaction among the HNF1A rs1169288, rs2464196 and rs2650000 SNPs was found to be associated with the risk of CAD. In GMDR analyses, a significant association of the HNF1A SNPs and CAD was found in one-to three-locus models. Moreover, we also found a strong associ- The haplotypes consist of four alleles in the order: rs1169288, rs2259820, rs2464196 and rs2650000 SNPs. difference between the traits and a potential gene-gene interaction should be taken into account.
The interactions of the HNF1A haplotypes and some environmental factors on the risk of CAD and IS are not known. In the present study, we found that the haplotype of A-C-G-A in nonsmokers was associated with a decreased risk for CAD. The present study did not show any association between the HNF1A SNPs and the risk of IS.
However, we firstly found that the A-C-G-A haplotype in men and the A-T-A-C haplotype in drinkers were associated with a decreased risk for IS, whereas the A-T-A-C haplotype in nondrinkers was associ- In conclusion, to the best of our knowledge, this is the first study to link HNF1A polymorphisms with serum lipid levels and the risk of CAD or IS in the Chinese populations. We confirmed that the SNPs in the HNF1A were associated with higher serum ApoA1 levels. Our results indicate that the polymorphic variability in the HNF1A locus may be a factor involving in the risk of CAD and IS.
